Back to results

Wake Forest University

UNIQUE PHARMACODYNAMIC PROFILE OF METHYLPHENIDATE: SELF-ADMINISTRATION-INDUCED DOPAMINE SYSTEM ALTERATIONS

Abstract

dc:description.abstract

Methylphenidate (MPH), the active compound in the medication Ritalin, is commonly diverted for off-label use. It is abused at high rates in both the adolescent and adult population; however, until recently, the neurochemical effects of MPH abuse had not been explored in depth. Pharmacologically MPH is a dopamine transporter (DAT) blocker with the same mechanism of action and equivalent potency at the DAT as cocaine. Although MPH is categorized as a DAT blocker, its pharmacological actions are distinct from both blockers and releasers in regards to both its acute effects and the compensatory alterations associated with self-administration of the compound. This work has elucidated the neurochemical consequences of MPH self-administration, whereby MPH administration by a number of paradigms results in consistent neurochemical adaptations characterized by increased maximal rates of uptake (Vmax), increased DAT levels, increased evoked dopamine (DA) release, and an increased potency to inhibit the DAT for MPH and releasers, but not blockers. These changes are opposite from the documented changes that occur following cocaine self-administration, further suggesting that the neurochemical consequences of MPH are unique, and cannot be predicted based on previous literature of compounds of the same psychostimulant class, such as cocaine. The changes directly at the DAT following MPH self-administration are consistent with microdialysis and behavioral analysis that demonstrate increased MPH and amphetamine (AMPH)-induced DA overflow, but not cocaine, and increased reinforcing efficacy of AMPH and MPH, but not cocaine. The increases in the reinforcing efficacy of MPH and releasers such as AMPH, suggests that these compounds may having significant abuse liability following MPH abuse in the adolescent and adult populations.

Degree

thesis:*
Grantor dc:publisher
Wake Forest University
Year dc:date.issued
2013

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Calipari, Erin Sue

Subjects

dc:subject × 1

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/10339/39143
OAI identifier oai:identifier
oai:wakespace.lib.wfu.edu:10339/39143

Chain of custody

source
Harvested from
Wake Forest University
Base URL
wakespace.lib.wfu.edu/oai/request
Last updated
2026-07-27
Source record
OAI-PMH GetRecord
related terms
citation

Calipari, Erin Sue. UNIQUE PHARMACODYNAMIC PROFILE OF METHYLPHENIDATE: SELF-ADMINISTRATION-INDUCED DOPAMINE SYSTEM ALTERATIONS. Wake Forest University, 2013. http://hdl.handle.net/10339/39143